We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




"RDA on a Chip” Detects Genomic Abnormalities

By Biotechdaily staff writers
Posted on 17 Oct 2003
Researchers have developed a new technique called ROMA (representational oligonucleotide microarray analysis) for the detection of human genomic abnormalities in cancer genomes and in healthy genomes.

ROMA combines microarray technology with the powerful and versatile gene discovery method called representational difference analysis (RDA), which enables researchers to "clone the differences” between any two sets of DNA. More...
This makes ROMA "RDA on a chip.”

Investigators at Cold Spring Harbor Laboratory (NY, USA) employed ROMA to achieve an average resolution of 30 kb throughout the genome, and showed that resolutions as high as a probe every 15 kb were practical. In cancer genomes, they detected amplifications and large and small homozygous and hemizygous deletions. One surprising outcome was that between normal human genomes, they frequently detected large (100 kb to 1 Mb) deletions or duplications. Their findings were reported September 15, 2003, in the online edition of Genome Research.

The authors predict that ROMA will assist in the discovery of genes and markers important in cancer and the discovery of loci that may be important in inherited predispositions to disease.




Related Links:
Cold Spring Harbor Laboratory

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.